Compare ClearPoint Neuro Inc (CLPT) vs Funko Inc (FNKO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ClearPoint Neuro Inc vs Funko Inc — how do they compare? ClearPoint Neuro Inc trades at $14.89 (market cap $454.21M), while Funko Inc trades at $5.89 (market cap $332.33M). The key difference: ClearPoint Neuro Inc is the larger of the two by market cap, and Funko Inc is trading nearer its 52-week high, ClearPoint Neuro Inc nearer its low. Which is the better fit depends on your goals.
| CLPT | FNKO | |
|---|---|---|
Market Cap | $454.21M | $332.33M |
Sector | Health | Consumer Staples |
52-Week High | $29.60 | $6.35 |
52-Week Low | $8.66 | $2.65 |
Enterprise Value | $488.79M | $552.98M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ClearPoint Neuro (CLPT) trades at $14.56, down slightly by 0.07% today, with a bullish technical signal from moving averages but mixed oscillators. The company reported Q2 2026 revenue growth to $42 million but missed earnings estimates with a loss of $0.38 per share, reflecting ongoing investment in clinical and preclinical services. Despite negative net income margins and cash flow challenges, analyst consensus remains unanimously bullish with 3 buy ratings.
The outlook hinges on successful execution of growth initiatives in neuro drug delivery and regulatory progress with partners, though high valuation multiples and persistent losses pose significant risks. Near-term catalysts include Q3 2026 earnings and partner developments, but investors face volatility from operational cash burn and competitive pressures.
Funko (FNKO) trades at $6.19, up 5.27% with bullish technical signals and strong recent earnings beats. The company shows improving fundamentals with Q2 2026 revenue growth of 7% to $207.7 million and raised EBITDA guidance. Despite negative net margins, the stock trades at attractive valuation multiples with P/S of 0.35 and EV/EBITDA of 6.46. Recent management changes and successful product launches support positive momentum.
Outlook remains cautiously optimistic with analyst consensus leaning toward hold/buy. Key opportunities include continued execution of the 'Make Culture POP!' strategy and margin improvement, while risks include persistent negative profitability and competitive pressures in the collectibles market. The stock presents value potential if operational improvements continue.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ClearPoint Neuro Inc
ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.
Read more on CLPT →About Funko Inc
Funko Inc is a US-based pop culture consumer products company. It creates whimsical, fun, and different products which enable the customer to express their affinity for their favorite through movie, TV show, video game, musician or sports team. The company holds licenses and the rights to create tens of thousands of characters including Game of Thrones, Walking Dead, Disney, Marvel, Harry Potter, Fallout, and others. Its products include Pop, Dorbz, Mystery Vinyl, Plush, Action Figures, and Others. The company sells its products through a diverse network of retail customers across multiple retail channels, including specialty retailers, mass-market retailers, and e-commerce sites.
Read more on FNKO →
